COUPANG INC (CPNG)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-30
$14.37-1.37%
Close 2026-10-30 · 1-day change
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-30
Research Workspace
Put CPNG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue growth is slowing — up about 10% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 37%, softest on returns on capital.
View QualityManagement screens weak on capital allocation, earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 33% growth a year, above the roughly 17% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 57% in its worst 12-month stretch.
View RiskCPNG’s case rests on stronger sales growth and eventual profitability despite mixed earnings quality and recent weak performance. Revenue rose 4% year over year in Q2 FY2026, and the quarter beat non-GAAP EPS consensus. It trades at 0.7× sales versus a 0.8× peer median and its 0.8× historical multiple. The market is pricing in more growth than we forecast, so expectations look full. Management running behind on a stated commitment threatens confidence; our model puts the next-quarter miss probability near 27%. Peer multiples imply a price about 34% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. CPNG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering CPNG (as of Oct 2026).
Based on 5 Wall Street analysts offering 12-month price targets for CPNG in the last 4 months.
Continue this research
Compare CPNG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CPNG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Broadline Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put CPNG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Grow Product Commerce segment revenue and customer base
Regulatory risks weigh on growth potential.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $14.37
The last 12 months of price, then the range of analyst 12-month targets from today’s $14.37.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Grow Product Commerce segment revenue and customer base
Softer Q2 guidance raises concerns about growth.
Threatens: Improve overall profitability and reduce operating losses
FTC investigation could impact profitability and operations.
Legal issues could hinder growth and profitability objectives.
Advances: Grow Product Commerce segment revenue and customer base
Significant revenue growth supports product commerce objectives.
Threatens: Address regulatory challenges
Significant fine impacts regulatory standing and profitability.
Threatens: Improve overall profitability and reduce operating losses
Record fine over data breach severely impacts profitability.
Advances: Improve profitability
Fee-free service could enhance profitability and customer growth.